GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 6:02 PM ET

    Baxter International Inc. fell $1.07 or 1.5 percent, to $70.31. Bristol-Myers Squibb Co. fell$. 87 or 1.4 percent, to $60.27. Hospira fell $1.35 or 2.1 percent, to $63.43.

  • Jan 30- Shares of Spark Therapeutics Inc more than doubled in their debut, valuing the gene-therapy company at nearly $1.5 billion and underscoring investor's interest in the field that recently produced a million-dollar drug. The company's shares opened at $45.10 in their debut on Friday, nearly double their IPO price of $23, and soared to a high of $50 with...

  • Midday Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 1:27 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $71.45. Bristol-Myers Squibb Co. fell$. 27 or. 4 percent, to $60.87. Hospira fell$. 62 or 1.0 percent, to $64.16.

  • Most active New York Stock Exchange-traded stocks Friday, 30 Jan 2015 | 1:27 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. fell. 1 percent to $32.92 with 53,984,300 shares traded. Bank of America Corp. fell 1.8 percent to $15.15 with 95,607,400 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 11:13 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $71.55. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.60. Hospira fell $1.05 or 1.6 percent, to $63.73.

  • Jan 30- Eli Lilly and Co cut its 2015 revenue forecast, issued earlier this month, as the U.S. drugmaker expects a bigger hit from a stronger dollar. Large U.S. healthcare companies such as Johnson& Johnson, Pfizer Inc and Bristol-Myers Squibb Co have in the past weeks issued 2015 earnings forecasts below Wall Street expectations, citing the stronger dollar.

  • Final Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 6:14 PM ET

    Baxter International Inc. rose $1.22 or 1.7 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.14. Hospira rose$. 13 or. 2 percent, to $64.78.

  • Abbott CEO losing no sleep over stronger dollar Thursday, 29 Jan 2015 | 3:15 PM ET

    Jan 29- Abbott Laboratories' chief executive officer is not worried about the stronger dollar, telling analysts on Thursday his company will better withstand its painful effects than rivals due to its European factories and growing sales of nutritional products, medical diagnostics and medical optics. Half of its sales are in emerging markets, like China and...

  • Midday Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $60.72. Hospira fell$. 68 or 1.1 percent, to $63.97.

  • Most active New York Stock Exchange-traded stocks Thursday, 29 Jan 2015 | 1:23 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. was unchanged at $32.70 with 14,565,000 shares traded. Bank of America Corp. rose 1.0 percent to $15.35 with 45,663,700 shares traded.

  • Jan 29- Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, forecast 2015 sales and earnings below analysts' expectations, becoming the latest U.S. healthcare company to warn about a strengthening dollar. The company expects profit to be hit by 58 cents in 2015. It forecast $7.22 to $7.40, excluding special items, below analysts'...

  • Early Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 77 or 1.3 percent, to $60.56. Hospira fell$. 49 or. 8 percent, to $64.16.

  • Harley-Davidson earnings fall but edge forecasts Thursday, 29 Jan 2015 | 10:35 AM ET
    Harley-Davidson riders reveal Project LiveWire, the first electric Harley-Davidson motorcycle, last June in New York.

    Harley-Davidson's earnings slipped as a stronger U.S. dollar hurt the motorcycle maker's bottom line, which still topped analyst expectations.

  • MILWAUKEE— Harley-Davidson's fourth-quarter earnings slipped as a stronger U.S. dollar hurt the motorcycle maker's bottom line, which still topped analyst expectations. Analysts expected, on average, earnings of 33 cents per share, according to Zacks Investment Research. Harley-Davidson Inc. shares climbed 71 cents to $63 in premarket trading Thursday 30...

  • Final Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 66 or 1.1 percent, to $61.33. Hospira fell$. 84 or 1.3 percent, to $64.65.

  • Midday Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 1:21 PM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $70.83. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $62.47. Hospira fell$. 21 or. 3 percent, to $65.28.

  • Most active New York Stock Exchange-traded stocks Wednesday, 28 Jan 2015 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AK Steel Holding Corp. fell 7.8 percent to $3.92 with 26,056,200 shares traded. AT&T Inc. fell. 4 percent to $32.68 with 45,235,400 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 10:41 AM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $70.93. Bristol-Myers Squibb Co. rose$. 66 or 1.1 percent, to $62.65. Hospira rose$. 30 or. 5 percent, to $65.79.

  • The real Deflategate you should be freaking about Wednesday, 28 Jan 2015 | 8:59 AM ET

    Deflation is an economic nightmare that is starting to look like a reality, and central bankers shouldn't be the only ones freaking out.

  • Why Pfizer will remain strong  Tuesday, 27 Jan 2015 | 6:45 PM ET

    Raghuram Selvaraju, Managing Director of Equity Research for Healthcare at MLV & Co, says there's lots of leverage the company can employ to sustain strong earnings growth.